Leishmania infections: Molecular targets and diagnosis

. 2017 Oct ; 57 () : 1-29. [epub] 20170131

Jazyk angličtina Země Anglie, Velká Británie Médium print-electronic

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/pmid28159546
Odkazy

PubMed 28159546
DOI 10.1016/j.mam.2016.11.012
PII: S0098-2997(16)30045-0
Knihovny.cz E-zdroje

Progress in the diagnosis of leishmaniases depends on the development of effective methods and the discovery of suitable biomarkers. We propose firstly an update classification of Leishmania species and their synonymies. We demonstrate a global map highlighting the geography of known endemic Leishmania species pathogenic to humans. We summarize a complete list of techniques currently in use and discuss their advantages and limitations. The available data highlights the benefits of molecular markers in terms of their sensitivity and specificity to quantify variation from the subgeneric level to species complexes, (sub) species within complexes, and individual populations and infection foci. Each DNA-based detection method is supplied with a comprehensive description of markers and primers and proposal for a classification based on the role of each target and primer in the detection, identification and quantification of leishmaniasis infection. We outline a genome-wide map of genes informative for diagnosis that have been used for Leishmania genotyping. Furthermore, we propose a classification method based on the suitability of well-studied molecular markers for typing the 21 known Leishmania species pathogenic to humans. This can be applied to newly discovered species and to hybrid strains originating from inter-species crosses. Developing more effective and sensitive diagnostic methods and biomarkers is vital for enhancing Leishmania infection control programs.

Agence Nationale de Sécurité Sanitaire de l'Alimentation de l'Environnement et du Travail ANSES Laboratoire de Santé Animale Maisons Alfort Cedex France

Biology Centre Institute of Parasitology Czech Academy of Sciences České Budějovice Czech Republic; Department of Parasitology Faculty of Science Charles University Prague Prague Czech Republic

Biology Centre Institute of Parasitology Czech Academy of Sciences České Budějovice Czech Republic; Faculty of Sciences University of South Bohemia České Budějovice Czech Republic; Canadian Institute for Advanced Research Toronto Canada

Division of Molecular Biotechnology and Functional Genomics Technical University of Applied Sciences Wildau Wildau Germany

French National Reference Centre on Leishmaniasis Montpellier University Montpellier France

Inserm U1065 Centre Méditerranéen de Médecine Moléculaire Université de Nice Sophia Antipolis Nice France

IRD UMI 233 INSERM U1175 Montpellier University Montpellier France; MIVEGEC UMR CNRS5290 IRD224 Université de Montpellier Centre IRD Montpellier France

MIVEGEC UMR CNRS5290 IRD224 Université de Montpellier Centre IRD Montpellier France; Intertryp UMR IRD177 Centre IRD de Montpellier Montpellier France

School of Biotechnology Dublin City University Dublin Ireland

Service de Parasitologie Mycologie Hôpital de l'Archet Centre Hospitalier Universitaire de Nice Nice France; Inserm U1065 Centre Méditerranéen de Médecine Moléculaire Université de Nice Sophia Antipolis Nice France

Service de Parasitologie Mycologie Hôpital de l'Archet Centre Hospitalier Universitaire de Nice Nice France; Inserm U1065 Centre Méditerranéen de Médecine Moléculaire Université de Nice Sophia Antipolis Nice France; MIVEGEC UMR CNRS5290 IRD224 Université de Montpellier Centre IRD Montpellier France

Service de Parasitologie Mycologie Hôpital de l'Archet Centre Hospitalier Universitaire de Nice Nice France; MIVEGEC UMR CNRS5290 IRD224 Université de Montpellier Centre IRD Montpellier France

Unit of Vector borne Diseases and International Health Istituto Superiore di Sanità Rome Italy

Citace poskytuje Crossref.org

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...